Cargando…
Keynote 407: the combination of pembrolizumab and chemotherapy cracks the shell of squamous cell lung cancer
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354136/ https://www.ncbi.nlm.nih.gov/pubmed/32676347 http://dx.doi.org/10.21037/tlcr-20-400 |
| _version_ | 1783558021958336512 |
|---|---|
| author | Viteri, Santiago Cabrera-Gálvez, Carlos Rosell, Rafael |
| author_facet | Viteri, Santiago Cabrera-Gálvez, Carlos Rosell, Rafael |
| author_sort | Viteri, Santiago |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7354136 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73541362020-07-15 Keynote 407: the combination of pembrolizumab and chemotherapy cracks the shell of squamous cell lung cancer Viteri, Santiago Cabrera-Gálvez, Carlos Rosell, Rafael Transl Lung Cancer Res Editorial Commentary AME Publishing Company 2020-06 /pmc/articles/PMC7354136/ /pubmed/32676347 http://dx.doi.org/10.21037/tlcr-20-400 Text en 2020 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Viteri, Santiago Cabrera-Gálvez, Carlos Rosell, Rafael Keynote 407: the combination of pembrolizumab and chemotherapy cracks the shell of squamous cell lung cancer |
| title | Keynote 407: the combination of pembrolizumab and chemotherapy cracks the shell of squamous cell lung cancer |
| title_full | Keynote 407: the combination of pembrolizumab and chemotherapy cracks the shell of squamous cell lung cancer |
| title_fullStr | Keynote 407: the combination of pembrolizumab and chemotherapy cracks the shell of squamous cell lung cancer |
| title_full_unstemmed | Keynote 407: the combination of pembrolizumab and chemotherapy cracks the shell of squamous cell lung cancer |
| title_short | Keynote 407: the combination of pembrolizumab and chemotherapy cracks the shell of squamous cell lung cancer |
| title_sort | keynote 407: the combination of pembrolizumab and chemotherapy cracks the shell of squamous cell lung cancer |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354136/ https://www.ncbi.nlm.nih.gov/pubmed/32676347 http://dx.doi.org/10.21037/tlcr-20-400 |
| work_keys_str_mv | AT viterisantiago keynote407thecombinationofpembrolizumabandchemotherapycrackstheshellofsquamouscelllungcancer AT cabreragalvezcarlos keynote407thecombinationofpembrolizumabandchemotherapycrackstheshellofsquamouscelllungcancer AT rosellrafael keynote407thecombinationofpembrolizumabandchemotherapycrackstheshellofsquamouscelllungcancer |